Ad is loading...
GLSI
Price
$12.56
Change
-$1.03 (-7.58%)
Updated
Nov 15 closing price
One day until earnings call
SLRX
Price
$1.34
Change
-$0.04 (-2.90%)
Updated
Nov 15 closing price
Ad is loading...

GLSI vs SLRX

Header iconGLSI vs SLRX Comparison
Open Charts GLSI vs SLRXBanner chart's image
Greenwich LifeSciences
Price$12.56
Change-$1.03 (-7.58%)
Volume$43.99K
CapitalizationN/A
Salarius Pharmaceuticals
Price$1.34
Change-$0.04 (-2.90%)
Volume$33.48K
CapitalizationN/A
GLSI vs SLRX Comparison Chart
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GLSI vs. SLRX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Sell and SLRX is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (GLSI: $12.56 vs. SLRX: $1.34)
Brand notoriety: GLSI and SLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 155% vs. SLRX: 8%
Market capitalization -- GLSI: $165.1M vs. SLRX: $1.93M
GLSI [@Biotechnology] is valued at $165.1M. SLRX’s [@Biotechnology] market capitalization is $1.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileSLRX’s FA Score has 1 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • SLRX’s FA Score: 1 green, 4 red.
According to our system of comparison, SLRX is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 2 TA indicator(s) are bullish while SLRX’s TA Score has 2 bullish TA indicator(s).

  • GLSI’s TA Score: 2 bullish, 7 bearish.
  • SLRX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, both GLSI and SLRX are a bad buy in the short-term.

Price Growth

GLSI (@Biotechnology) experienced а -12.72% price change this week, while SLRX (@Biotechnology) price change was -10.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

GLSI is expected to report earnings on Feb 26, 2025.

SLRX is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($165M) has a higher market cap than SLRX($1.93M). GLSI YTD gains are higher at: 19.392 vs. SLRX (-74.231). SLRX has higher annual earnings (EBITDA): -6.73M vs. GLSI (-10.53M). GLSI has more cash in the bank: 7.23M vs. SLRX (3.27M). GLSI (0) and SLRX (0) have equivalent revenues.
GLSISLRXGLSI / SLRX
Capitalization165M1.93M8,545%
EBITDA-10.53M-6.73M156%
Gain YTD19.392-74.231-26%
P/E RatioN/AN/A-
Revenue00-
Total Cash7.23M3.27M221%
Total DebtN/A117K-
FUNDAMENTALS RATINGS
SLRX: Fundamental Ratings
SLRX
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSISLRX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STRCX10.00N/A
N/A
Sterling Capital Behavioral Intl Eq R6
VSENX61.86-0.60
-0.96%
JPMorgan Small Cap Equity R6
WPOIX12.94-0.18
-1.37%
Weitz Partners III Opportunity Investor
SUGCX11.70-0.18
-1.52%
Pioneer Global Sustainable Growth C
WSGAX13.26-0.22
-1.63%
Delaware Ivy Small Cap Growth A

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ORMP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-7.58%
ORMP - GLSI
35%
Loosely correlated
-4.50%
ETNB - GLSI
34%
Loosely correlated
-9.37%
DNLI - GLSI
32%
Poorly correlated
-11.95%
SAGE - GLSI
31%
Poorly correlated
-5.03%
NAUT - GLSI
30%
Poorly correlated
-6.50%
More

SLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRX has been closely correlated with MBIO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if SLRX jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRX
1D Price
Change %
SLRX100%
-2.90%
MBIO - SLRX
71%
Closely correlated
-3.14%
NRSN - SLRX
32%
Poorly correlated
-5.38%
FRTX - SLRX
25%
Poorly correlated
+0.35%
GLSI - SLRX
25%
Poorly correlated
-7.58%
AZTR - SLRX
25%
Poorly correlated
+1.09%
More